Zoladex LA Injection (10.8mg), which contains the active ingredient Goserelin acetate, is a synthetic hormone used primarily in the treatment of hormone-sensitive conditions such as prostate cancer, breast cancer, and endometriosis. This medication functions as a gonadotropin-releasing hormone (GnRH) agonist, effectively reducing the production of sex hormones like testosterone and estrogen in the body. Zoladex is administered via subcutaneous injection, typically once every three months, making it a convenient option for patients requiring long-term hormone therapy. The formulation of Zoladex LA Injection ensures a sustained release of Goserelin, allowing for consistent therapeutic effects while minimizing the frequency of administration. This drug is crucial in managing conditions that are influenced by hormonal levels, providing patients with a viable treatment option to control disease progression and alleviate symptoms.